2026³â 01¿ù 08ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation

´º½ºÀÏÀÚ: 2025-11-20

NEW YORK -- IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic collaboration with BASF, one of the world’s largest chemical companies and leader in sustainable product innovation, to accelerate the development of IFF’s Designed Enzymatic Biomaterials™ technology platform and create next-generation enzyme technologies for fabric, dish and personal care as well as industrial cleaning applications.

This collaboration brings together two industry leaders with a shared vision: to develop high-performance, sustainable solutions that meet evolving consumer and market demands. By combining advanced chemical capabilities and expertise in biotechnology and protein engineering from IFF and BASF, the partnership aims to deliver breakthrough solutions at scale that enhance cleaning performance, improve personal care formulations, reduce environmental impact, and support the transition to a more sustainable future.

“We are very excited about the collaboration with BASF to jointly unlock new potential in enzyme and polymer technologies,” said Erik Fyrwald, CEO of IFF. “Our partnership enables us to develop market-driven solutions that create sustainable value for both the industry and the environment.”

“This partnership marks a strategically significant step for both companies,” said Michael Heinz, member of the board of executive directors at BASF. “By combining our research and development expertise, we are creating the foundation to bring large-scale innovative solutions to market faster for our customers.”

The joint effort will focus on innovative enzyme systems and biobased polymers, enabling customers to achieve superior performance while reducing resource consumption. Both companies will maintain independent operations and competitive positioning, while leveraging complementary strengths to accelerate innovation and expand choices for customers worldwide.

Cautionary Statement under the Private Securities Litigation Reform Act of 1995
This press release contains “forward-looking statements” within the meaning of the U.S. federal securities laws. These statements relate to future events or performance and often include words such as “plan”, “expect,” “anticipate,” “intend,” “believe,” “will,” “may,” and similar expressions. Actual results may differ materially due to risks and uncertainties. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update them except as required by law.



 Àüü´º½º¸ñ·ÏÀ¸·Î

CES 2026: GIGABYTE is ¡°AI Forward,¡± Showcasing AI Factory, Physical AI, and Agentic AI Solutions
Abu Dhabi¡¯s TII Launches Falcon-H1 Arabic, Establishing the World¡¯s Leading Arabic AI Model
Rising Demand for AI Power Accelerates S-Fuelcell¡¯s Grid-Free, On-Site PEM Expansion
NetApp Expands EMEA, LATAM Reach with Willem Hendrickx Appointment as AI Demand Surges
BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
Semiconductor Quarterly Revenue Surpasses $200bn for the First Time as Industry-Wide Growth Accelerates
From Pilots to Profit: NTT DATA's 2026 Global AI Report Shows How Top Performers Turn AI Vision Into Value

 

AI Won¡¯t Transform Mobility Without Unprecedented Collaboration, Stud...
IBMI SNQ and ICHOM Forms Strategic Partnership in Asia, Advancing Pati...
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-c...
Hanseo University Expands Aviation Training Program with New Frasca Fl...
University of Maryland Launches Innovative Clinician Training Program ...
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congres...
Famenity's Brain Factor-7¢ç Gains Global Momentum as Clinically Valida...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..